Study Of Dato-Dxd As Monotherapy And In Combination With Anti-Cancer Agents In Patients With Advanced Solid Tumours (Tropion-Pantumor03)
Posted Date: Apr 26, 2024
- Investigator: Davendra Sohal
- Specialties: Cancer, Colorectal Cancer, Prostate Cancer
- Type of Study: Drug
This Phase II, open-label, uncontrolled, multicentre study evaluating the efficacy and safety of Dato-DXd as monotherapy (MONO) and in combination with anticancer agents (COMBO) in various advanced solid tumour types.
Criteria:
Null
Keywords:
Gastric Cancer, Biliary Tract Cancer
For More Information:
Haley Appelman
NULL
cancer@uchealth.com